intravenous immune globulin
The term “intravenous immune globulin” means an approved pooled plasma derivative for the treatment in the patient’s home of a patient with a diagnosed primary immune deficiency disease, but not including items or services furnished before January 1, 2024 , related to the administration of the derivative, if a physician determines administration of the derivative in the patient’s home is medically appropriate.